Thromboembolism – Page 2 – Communicable Diseases Research

COVID-19 and Peripheral Artery Thrombosis: A Mini Review

Review article

Published on 2022-10-012022-10-05
Journal: Current problems in cardiology [Category] COVID19(2023년), SARS, 변종, 진단,

Thromboembolic events in deceased patients with proven SARS-CoV-2 infection: Frequency, characteristics and risk factors

Article

Published on 2022-10-012023-07-10
Journal: Thrombosis research [Category] COVID19(2023년),

[키워드] Autopsy body mass index COVID-19 Hereditary thrombophilia intensive care unit Thromboembolism
[DOI] 10.1016/j.thromres.2022.08.021 PMC 바로가기

Fatal Form of COVID-19 in a Young Male Bodybuilder Anabolic Steroid Using: The First Autopsied Case

Article

Published on 2022-09-292022-11-15
Journal: Medicina [Category] SARS, 진단,

The impact of platelets on pulmonary microcirculation throughout COVID-19 and its persistent activating factors

Article

Published on 2022-09-282022-11-15
Journal: Frontiers in Immunology [Category] 치료제,

[키워드] activate activating addition aggregation antiplatelet Blood coagulation factor complex convalescent COVID-19 COVID-19 patients disease severity disorders endothelial injury Factor Gas exchange hypercoagulability hypercoagulable hypercoagulable states Hypoxemia hypoxia immune cells impaired lung function impairment incidence Inflammation Inflammatory mediators inhibiting Intervention intrinsic involved Lung function manifestation marker microvesicle Microvesicles Mild Mortality Phosphatidylserine Platelet platelet activation Platelets promote PROTECT pulmonary permeability pulmonary vasculitis reactivity reducing resulting risk severe cases stages the disease therapy Thromboembolism thrombosis thrombotic event tissue Treatment vessel walls with COVID-19
[DOI] 10.3389/fimmu.2022.955654 PMC 바로가기

SARS-CoV-2 infection- induced growth factors play differential roles in COVID-19 pathogenesis

SARS-CoV-2 감염 유발 성장 인자는 COVID-19 발병 기전에서 다른 역할을 합니다

Article

Published on 2022-09-012022-09-11
Journal: Life sciences [Category] COVID19(2023년), MERS, SARS, 바이오마커, 치료기술,

[키워드] adverse effect adverse effects angiopoietin association COVID-19 COVID-19 pathogenesis COVID-19 patient Critical Critically ill cytokine Cytokine storm Cytokine storms Cytokines D-dimer disease dysregulation EGF elevated Endothelial dysfunction EPO erythropoietin exhibited G-CSF growth factor Growth factors HGF Hospitalized ICU Inflammation Injury inverse correlation investigation marker moderate Myoglobin negative correlation non-ICU occur P-selectin Pathogenesis pathogenesis of COVID-19 pathophysiology PDGF plasma positive correlation reflected remained repair SARS-COV-2 infection selectin specific disease Thromboembolism tissue tissue injury Tissue injury. upregulated vague VEGF was performed
[DOI] 10.1016/j.lfs.2022.120703 PMC 바로가기 [Article Type] Article

Assessment of thromboembolism risk in COVID-19 patients with cardiovascular disease risk factors: Analysis of a Japanese Nationwide Registry

Research article

Published on 2022-08-012022-10-05
Journal: Thrombosis research [Category] COVID19(2023년), SARS, 바이오마커,

[키워드] abnormality Accuracy Acute kidney injury acute respiratory distress syndrome adjusted Admission AKIAcute Kidney Injury Analysis ARDSacute respiratory distress syndrome area under the curve assessment AUCarea under the curve BNPbrain natriuretic peptide brain natriuretic peptide C-reactive protein cardiovascular disease cardiovascular disease risk factor chest X-ray Coagulation coefficient cohort study confidence interval coronavirus disease-2019 COVID-19 patient COVID-19coronavirus disease-2019 CRPC-reactive protein CVDRFcardiovascular disease risk factor D-dimer D-dimer level Deep vein thrombosis develop DVTdeep vein thrombosis embolic event Factor Hospitalization hospitalized patient identify In-hospital in-hospital mortality Invasive mechanical ventilation Japanese lactate dehydrogenase LASSOleast absolute shrinkage and selection operator LDHlactate dehydrogenase least absolute shrinkage and selection operator limitation Male sex N-terminal prohormone of brain natriuretic peptide NT-pro-BNPN-terminal prohormone of brain natriuretic peptide Occurrence operator parameter Patient patients with COVID-19 potential risk Predictive Predictive model PTEpulmonary thromboembolism Pulmonary thromboembolism receiver operating characteristic reducing Registered registry reported Result risk risk factor ROCreceiver operating characteristic shown significantly Support the primary endpoint thromboembolic Thromboembolic events Thromboembolism Venous Thromboembolism VTEVenous Thromboembolism was performed WBCWhite blood cell White blood cell with COVID-19
[DOI] 10.1016/j.thromres.2022.06.007 [Article Type] Research article

Extracardiac Prothrombotic Effects of COVID-19

COVID-19의 심장 외 혈전 효과

Review

Published on 2022-08-012022-09-11
Journal: Cardiology clinics [Category] SARS, 치료기술,

SARS-CoV-2 infection induces soluble platelet activation markers and PAI-1 in the early moderate stage of COVID-19

SARS-CoV-2 감염은 COVID-19의 초기 중등도 단계에서 가용성 혈소판 활성화 마커 및 PAI-1을 유도합니다

Article

Published on 2022-08-012022-09-11
Journal: International journal of laboratory hematology [Category] MERS, SARS, 바이오마커,

[키워드] activated activated partial thromboplastin time activation of platelet activation of platelets Analysis aPTT CD40 ligand Coagulation coagulation dysfunction coagulation factor Coagulation factors Coagulation system coagulation test coagulation tests Comorbidity correlated COVID-19 COVID-19 patient COVID-19 patients COVID-19 severity D-dimer dysfunction dysregulated elevated Factor fibrinogen flow cytometry FXIII help hospitalized COVID-19 patient hospitalized COVID-19 patients induce inhibitor intensive care limit marker moderate Moderate COVID-19 molecular Multiplex assay P-selectin partial thromboplastin time Pathogenesis pathogenesis of COVID-19 pathway performed plasma plasminogen Platelet platelet activation Platelets Pneumonia progression prothrombin Prothrombin time recruited reduction in required SARS-COV-2 infection severe cases severe COVID-19 severe patients severity significantly Stage TFPI the disease Thromboembolism THROMBOPLASTIN Thromboprophylaxis tissue Tissue Factor tissue factor pathway inhibitor tissue plasminogen activator
[DOI] 10.1111/ijlh.13829 PMC 바로가기 [Article Type] Article

A review of pathophysiological mechanism, diagnosis, and treatment of thrombosis risk associated with COVID-19 infection

Review article

Published on 2022-08-012022-10-05
Journal: IJC Heart & Vasculature [Category] 바이오마커, 임상, 진단, 치료법,

[키워드] abnormality absence Anticoagulant anticoagulation antithrombotic therapy Clinical outcome Coagulation Coagulopathy Consensus contraindication coronavirus COVID-19 COVID-19 patients COVID19 patients Critical Developing Diagnosis diagnosis of COVID-19 discharge Factor Guidance high risk hospitalized COVID-19 hospitalized patients increase in Infection Inflammation information intensity morbidity Mortality Myocardial pathophysiological mechanism Patient patients patients hospitalized prescribing Prophylactic randomized trial risk severe COVID-19 severe COVID-19 disease similarity stroke subject Thromboembolism thrombosis Thrombotic complications Treatment Venous Thromboembolism with COVID-19
[DOI] 10.1016/j.ijcha.2022.101068 [Article Type] Review article

Cardiopulmonary Imaging Utilization and Findings among Hospitalized COVID-19 Patients in Latin America: (From “RIMAC: Registry IMAging Cardiopulmonary among Hospitalized COVID-19 Patients in LATAM”)

Observational Study

Published on 2022-08-012022-10-04
Journal: Global Heart [Category] SARS, 임상,

[키워드] Admission America association Cardiopulmonary Cardiopulmonary Images carried Chest CT Comorbidities Comorbidity complications conducted COVID-19 COVID-19 hospitalization diabetes Diagnosis discharge Evolution finding ground glass heart highest Hospitalization hospitalized patient hypertension ICU imaging In-hospital death in-hospital mortality information Inpatients interstitial lack LATAM Latin Latin America lung magnetic resonance imaging males median age Myocardial infarction nine pandemic performed predominant prevalent Prognosis Region regions registry RIMAC SARS-CoV-2 severity South America syndrome the SARS-CoV-2 Thromboembolism utilization X-ray
[DOI] 10.5334/gh.1134 PMC 바로가기 [Article Type] Observational Study